Vitamin D and the landscape for the ideal study design to measure cancer preventive effects

With growing global prosperity, it seems paradoxical that many people worldwide should have a vitamin deficiency. And yet, vitamin D deficiency is a growing public health problem in many countries. Suboptimal vitamin D levels, defined as below 50nmol/L, have been found in as many as 60% of people in European countries [1] and 42% in […]

How can genomics help us understand the hidden causes of cancer

We are well used to hearing about new large-scale cancer genomics studies, and how they might provide insights into new treatments for cancer, although what is often of more interest to those of us at EPICentre is how genomics can help unravel the causes of cancer, in particular for those cancers for which traditional epidemiology […]

What is the probability of developing cancer?

One in two of us will develop cancer at some point over the course of lifetime. This is the result of a recent study that was published recently in the British Journal of Cancer (1). Epidemiologists from Queen Mary’s University of London, UK, estimated the lifetime risk of developing cancer in the UK using data […]